Carbon nanotechnology has emerged as a transformative force in the pharmaceutical field, offering innovative solutions for drug delivery, diagnostics, and therapeutics. Engineered carbon-based nanomaterials, such as carbon nanotubes and graphene, exhibit unique properties that make them ideal candidates for various biomedical applications. These nanomaterials provide a high surface area and tunable surface chemistry, enabling precise control over drug loading and release kinetics.
In drug delivery, carbon nanocarriers can enhance the solubility and stability of poorly water-soluble drugs, improving their bioavailability. Additionally, the exceptional conductivity of carbon nanotubes has facilitated the development of biosensors for sensitive and rapid detection of biomolecules, aiding in early disease diagnosis. Moreover, carbon nanomaterials possess excellent biocompatibility and can be functionalized to target specific tissues or cells, minimizing off-target effects. Despite the promising potential, challenges such as biodegradability and long-term toxicity need to be addressed to ensure the safe and effective integration of carbon nanotechnology into pharmaceutical applications. Ongoing research in this burgeoning field holds the promise of revolutionizing drug development and patient care, ushering in a new era of precision medicine.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India